HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatic pseudocapillarisation and atherosclerosis in ageing.

Abstract
Cardiovascular disease secondary to atherosclerosis is the main cause of death and disability in industrialised countries, and ageing is the foremost risk factor for atherosclerosis. We present a hypothesis linking age-specific structural change in the liver with accepted pathogenic mechanisms leading to atherosclerosis. Ageing in the liver is associated with pseudocapillarisation of the sinusoidal endothelium, which is characterised by thickening of endothelium, basement membrane formation, and defenestration (loss of pores). Fenestrations (pores) normally form a liver sieve that allows passage of chylomicron remnants for subsequent uptake and metabolism by hepatocytes. Ageing is associated with impaired clearance of chylomicron remnants, postprandial hypertriglyceridaemia, and hence, atherosclerosis, which we propose is linked directly to loss of permeability of the liver sieve because of defenestration associated with pseudocapillarisation. Development of methods to maintain fenestrations of sinusoidal endothelium or to facilitate refenestration might be a new therapeutic strategy for management of cardiovascular disease in old people.
AuthorsDavid G Le Couteur, Robin Fraser, Victoria C Cogger, Allan J McLean
JournalLancet (London, England) (Lancet) Vol. 359 Issue 9317 Pg. 1612-5 (May 04 2002) ISSN: 0140-6736 [Print] England
PMID12047987 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Chylomicrons
  • Lipoproteins
Topics
  • Age Factors
  • Animals
  • Arteriosclerosis (etiology, metabolism)
  • Chylomicrons (metabolism)
  • Humans
  • Hyperlipidemias (complications)
  • Lipoproteins (metabolism)
  • Liver (blood supply, metabolism, ultrastructure)
  • Microscopy, Electron
  • Rats
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: